Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gefitinib and Radiotherapy in Glioblastoma Multiforme
NCT00238797Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Feb 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gefitinib in glioblastoma multiforme (GBM), sponsored by AstraZeneca. Started Feb 2003; status: completed.
02
Drugs
03
Conditions
glioblastoma multiforme (GBM)
Beyond the preview
Go deeper on NCT00238797.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00238797.